Insider · CIK 0001532023

Gangolli Julian S

Reports to the SEC for 5 companies · PITTSBURGH, PA

sec.gov

Transactions

Companies

Filings

CIK

0001532023

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	KRYSKrystal Biotech, Inc. · Restricted Stock UnitsA Award	Director	AAward	+471 sh	—	—	471
2026-09-14	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,187 sh	—	—	1,187
2025-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+287K sh	—	—	286,734
2025-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−30.1K sh	$3.65	−$110K	15,000
2024-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.6K sh	—	—	56,636
2024-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+71.2K sh	—	—	71,169
2024-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-05-20	KRYSKrystal Biotech, Inc.S Sale	Director	SSale	−7,090 sh	$164.34	−$1.17M	1,980
2024-05-20	KRYSKrystal Biotech, Inc.S Sale	Director	SSale	−10.9K sh	$163.71	−$1.79M	9,070
2024-05-20	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2024-05-20	KRYSKrystal Biotech, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$22.75	+$455K	20,000
2024-05-20	KRYSKrystal Biotech, Inc.S Sale	Director	SSale	−1,980 sh	$165.76	−$328K	0
2024-05-01	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,458
2024-05-01	Revance Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	45,106
2024-03-07	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+94.4K sh	—	—	94,441
2023-10-04	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+370K sh	—	—	370,282
2023-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,800 sh	—	—	6,800
2023-05-03	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+5,915 sh	—	—	5,915
2023-05-03	Revance Therapeutics, Inc.A Award	Director	AAward	+3,534 sh	—	—	30,106
2023-03-29	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.1K sh	—	—	41,065
2022-10-05	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+74.4K sh	—	—	74,398
2022-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,800 sh	—	—	6,800
2022-05-04	Revance Therapeutics, Inc.A Award	Director	AAward	+6,059 sh	—	—	26,572
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,756
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,343
2022-03-23	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.9K sh	—	—	21,878
2021-10-05	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44.5K sh	—	—	44,466
2021-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,800 sh	—	—	6,800
2021-05-05	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+7,551 sh	—	—	7,551
2021-05-05	Revance Therapeutics, Inc.A Award	Director	AAward	+4,013 sh	—	—	20,513
2021-03-24	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.9K sh	—	—	20,873
2020-10-05	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+151K sh	$0.51	+$77.5K	150,748
2020-07-17	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,000
2020-07-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	$0.99	+$34.5K	35,006
2020-06-30	KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,800 sh	—	—	6,800
2020-05-14	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-05-14	Revance Therapeutics, Inc.A Award	Director	AAward	+6,000 sh	—	—	16,500
2020-04-20	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-05-10	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	President, North America	MExercise/Conversion	−10.8K sh	—	—	0
2019-05-10	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	President, North America	MExercise/Conversion	−366K sh	—	—	0
2019-05-10	GW PHARMACEUTICALS PLCStock OptionsM Exercise/Conversion	President, North America	MExercise/Conversion	−27.4K sh	—	—	0
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−10.8K sh	$15.19	−$164K	106,548
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−31.4K sh	$15.12	−$474K	117,336
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−12K sh	$15.03	−$181K	148,704
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−145K sh	$14.96	−$2.17M	160,752
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−208K sh	$14.88	−$3.1M	305,916
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−65.3K sh	$14.80	−$966K	514,176
2019-05-10	GW PHARMACEUTICALS PLCS Sale	President, North America	SSale	−81.2K sh	$14.70	−$1.19M	579,444

Recent filings

Accepted (ET)
Sep 164
Gangolli Julian S0001532023-26-000002
SEC(opens sec.gov)
Oct 34
Gangolli Julian S0001649989-25-000007
SEC(opens sec.gov)
Jun 304
Gangolli Julian S0001532023-25-000005
SEC(opens sec.gov)
Feb 64
Gangolli Julian S0000950170-25-015688
SEC(opens sec.gov)
Oct 34
Gangolli Julian S0001415889-24-024711
SEC(opens sec.gov)
Jul 14
Gangolli Julian S0001532023-24-000010
SEC(opens sec.gov)
May 224
Gangolli Julian S0001532023-24-000008
SEC(opens sec.gov)
May 34
Gangolli Julian S0001479290-24-000086
SEC(opens sec.gov)
Mar 84
Gangolli Julian S0001415889-24-007335
SEC(opens sec.gov)
Oct 64
Gangolli Julian S0001209191-23-052271
SEC(opens sec.gov)
Jul 34
Gangolli Julian S0001711279-23-000049
SEC(opens sec.gov)
May 54
Gangolli Julian S0001479290-23-000064
SEC(opens sec.gov)

Companies

Address

C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701

PITTSBURGH, PA, 15203